Sage Therapeutics, Inc(NASDAQ:SAGE) 
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product p...
Website: http://www.sagerx.com
Founded: 2010
Full Time Employees: 675
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-01-31
P
O 7.39
H 7.39
L 7.16
C 7.25
V 1,464,665
10EMA 7.25
20EMA 7.25
60EMA 7.25
120EMA 7.25
250EMA 7.25